Chamber and committees

We want event organisers to be able to plan future activity with confidence, but we must continue to move very carefully to ensure continued suppression of COVID-19. The First Minister’s statement on 13 July confirmed that the size of events and stadia attendances will increase outdoors to 2,000 seated and 1,000 standing, and indoors to 400.

If event organisers want to organise an event when in Level 0 in excess of the relevant capacity limits, they must apply for approval to the relevant local authority.

This requires Event organisers to apply in line with the requirements of the Health Protection (Coronavirus) (Restrictions and Requirements) (Local Levels) (Scotland) Regulations 2021 as amended and provide the Local Authority with an application in writing (can be email) along with the minimum of:

• A description of the type of event (or events) proposed,
• An event plan for the event (or events) proposed, and
• A risk assessment for the event (or events) proposed, including what measures are proposed relating to the prevention or minimisation of the risk of the incidence and spread of coronavirus arising from the event (or events).

Live music performers should follow the performing arts guidance, available here . This was developed with a wide range of performing arts practitioners and looked ahead to outline details for the eventual resumption of live public performances. This guidance was last updated on 19 July. This update confirmed the move from 2 metre physical distancing to 1 metre in all indoor settings including in performing arts venues.

Separate guidance is available for live music performances which take place in hospitality settings. This reflects the different considerations that need to make in hospitality settings. The guidance for live entertainment in hospitality was updated on 16 July. The main purpose of the update was to indicate that live entertainment would be possible in general hospitality from 19 July.

With regards to live performances in events and stadia settings, the First Minister’s statement on 13 July confirmed maximum attendances as 2,000 in seated outdoor settings and 1,000 in standing outdoor settings, and indoors to 400. Organisers can apply to local authorities for higher attendance capacities.

To assist event organisers the Scottish Government has developed guidance for the sector, last update on 20 July: Coronavirus (COVID-19): events sector guidance - gov.scot (www.gov.scot)

The next review of restrictions will be in the week before 9 August when we hope to be able to move beyond Level 0 with baseline mitigations in place. We have consulted with the live performance sector widely on these mitigations to ensure we understand the impact they will have on businesses and their likely effectiveness.

This Scottish Government is committed to concluding the Local Governance Review within this parliament. During the first phase of the Review, the Scottish Government, COSLA and the community sector undertook a highly inclusive engagement process called Democracy Matters. People from diverse backgrounds overwhelmingly wanted to see bold changes to how power is shared. Further extensive engagement with communities - of place and interest - will be an important part of understanding how best to respond to people’s aspirations for genuine control over those decisions which affect them the most.

Statistics for the cervical screening programme that will allow comparisons with pre-Covid-19 pandemic uptake are due to be published by Public Health Scotland on 1 September 2021.

Comparable data on national performance for uptake in the breast and bowel screening programmes that will allow comparisons between uptake before and after the COVID-19 pandemic will be made available in 2022. NHS National Services Division advise that recent uptake in the bowel screening programme is similar to pre-pandemic levels at around 67%. Breast screening uptake is measured on an annual and 3 year cycle with current indications that uptake is running at an average of 80% across the whole programme, which is higher than uptake prior to the pandemic.

The bowel, breast and cervical screening programmes are governed by their respective programme boards, as well as the National Screening Oversight and the Scottish Screening Committee. They monitor and evaluate performance, including uptake rates, against a set of standards developed by Healthcare Improvement Scotland.

Additional information has been provided over the course of the pandemic, to reassure people that travel to attend a screening appointment during lockdown was classed as essential and that appropriate infection control measures are in place, so they can feel confident about attending.

In addition to providing information on NHS Inform, each programme has developed tailored communications to recognise additional concerns and challenges caused by the pandemic, and each continues to take steps to reduce barriers to screening and increase uptake.

The bowel screening programme includes supplementary information in home test kits, and has a dedicated helpline to answer all questions. Since the breast screening programme restarted last summer, breast screening centres have been contacting participants ahead of their appointments to confirm their intention to attend. To ensure sufficient capacity in the cervical screening programme to allow uptake of invitations following the pause, the Scottish Government provided just under £1 million to support capacity in sample taking and colposcopy services. To raise awareness and increase uptake we supported social media messaging during Cervical Screening Awareness week in June. Later this year, the Scottish Government will also be launching a campaign to communicate the benefits of cervical screening.

The Scottish Government recognises that the Covid-19 pandemic may have exacerbated inequalities in screening uptake, and we have committed £2 million over the next two years, to build a programme of evidence-based, sustainable and scalable projects that tackle inequalities in a systemic way.

If an individual has specific concerns arising from the results of a test they have taken, including related to their immunological response following vaccination, they should consult their primary clinician, who can determine whether further investigation is necessary.

There is a clear pattern between vaccination and testing positive for COVID-19 antibodies but the detection of antibodies alone is not a precise measure of the immunity protection given by vaccination.

It is not yet known how having detectable antibodies, now or at some time in the past, affects the chance of getting COVID-19 again as other parts of the immune system (T cell response) will offer protection. Antibody positivity is defined by a fixed amount of antibodies in the blood. A negative test result will occur if there are no antibodies or if antibody levels are too low to reach this threshold.

It is important to draw the distinction between testing positive for antibodies and having immunity. Following infection or vaccination, antibody levels can vary and sometimes increase but are still below the level identified as “positive” in this test, and other tests. This does not mean that a person has no protection against coronavirus (COVID-19) since an immune response does not rely on the presence of antibodies alone. We also do not yet know exactly how much antibodies need to rise to give protection. A person’s ‘T cell’ response will provide protection but is not detected by blood tests for antibodies. A person's immune response is affected by a number of factors, including health conditions and age. Additional information on the link between antibodies and immunity and the vaccine programme can be found in the latest ONS blog .

I chair the Construction Leadership Forum (CLF) that meets monthly with trade union, construction industry and government representatives collaborating on driving progress on the Construction Recovery Plan, which contains a range of practical actions to support the sector. The trade union representative is a positive, and active, member of the group. The CLF and I am committed to supporting the sector as best I can.

We are focused on delivering the maximum support for businesses and the economy as possible. Since the start of the pandemic, businesses have directly benefitted from more than £3.7bn in support – more than a third of total COVID-19 funding – £2.8bn in grants and £965m in COVID-19 non-domestic rates reliefs.

The Scottish Government supports measures to ensure that individuals and businesses pay a fair amount of tax. However, IR35 and VAT are both areas of policy fully reserved to the UK Government.

As I said in my reply to S6W-01546 on 29 July 2021, I chair the Construction Leadership Forum (CLF) that meets monthly and is driving progress on the Construction Recovery Plan. Actions implemented so far include: introduced new ways of working for managing infection control health and safety; work to retain the current and future apprentice pipeline and the Construction Pipeline Forecast Tool.

Policy on corporate insolvency is largely reserved to the UK Government. The temporary suspension on statutory demands and restrictions on petitions to wind up companies is scheduled to expire at the end of September. The Scottish Government would support action by the UK Government to enable further transitional provisions and to extend these protections.

We remain focused on delivering the maximum support for businesses and the economy as possible. Since the start of the pandemic, businesses have directly benefitted from more than £3.7bn in support – more than a third of total COVID-19 funding – £2.8bn in grants and £965m in COVID-19 non-domestic rates reliefs.

All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

The bowel, breast and cervical screening programmes were paused in March last year, and restarted last summer with the initial focus on higher-risk screening participants and those whose appointments were affected by the pause.

The bowel screening programme is currently sending home test kits at the same rate as before the pandemic, and no one is waiting for an invitation.

The breast screening programme is recovering, although infection control measures, including physical distancing and personal protective equipment, mean there are considerable capacity challenges. At this time, we do not have data on the number of people affected by the pause; however, we do know that slippage varies across health boards. The National Screening Oversight, the Scottish Screening Committee and the Breast Screening Programme Board continue to work with health boards to increase the number of breast screening appointments available.

Covid-19 also continues to present challenges in the cervical screening programme. However, prompts and reminders are being issued at pre-Covid rates. Estimates suggest that 5,786 invitations have not yet issued to people affected by the pause, but it should be stressed that this will be for a range of reasons, including participants being excluded from the programme after it restarted, or taking the opportunity to be screened at their GP ahead of their scheduled prompt to make an appointment.

The Breast Screening Programme invites women between the ages of 50 and 70 for routine breast screening every three years. This is in line with the recommendation provided by the UK National Screening Committee (UK NSC).

When the programme resumed on 3 August 2020 following a pause due to the impacts of COVID-19, the difficult decision was taken to maintain a pause on the option for those over the age of 70 to self-refer into the programme. This decision was taken on the basis that the risks and benefits of screening women over the age of 70 are not yet clear. Available capacity is therefore being used to prioritise women eligible for screening and for whom the benefits are already clearly established.

The option for women aged 71 and over to self-refer for a breast screening appointment will resume once capacity in all screening centres returns to pre-Covid or close to pre-Covid levels. This is based on the recommendation of the Scottish Screening Committee, the National Screening Oversight and the Breast Screening Programme Board, all three of whom are keeping the situation under regular review. They are also working closely with Health Boards to increase appointments and meet this criteria as soon as possible.

We continue to emphasise that everyone should remain symptom aware and report any symptoms to their GP immediately for these to be investigated.